Does Right-Hand Motor Impairment Affect Performance on Cognitive Testing in Parkinson's Disease?
Priyanka Rao1, Christine A Cooper2, Travis H Turner2
1College of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
Movement Disorders Clinical Practice
|June 9, 2025
Summary
Motor impairment in the dominant arm of people with Parkinson's (PwP) did not significantly affect graphomotor cognitive tests. This finding supports using these tests in clinical and research settings for PwP undergoing Deep Brain Stimulation (DBS).
Area of Science:
- Neuroscience
- Clinical Neurology
- Cognitive Psychology
Background:
- Motor disturbances in the dominant upper extremity are common in People with Parkinson's (PwP).
- These impairments can affect daily tasks like writing and typing.
- They may also influence cognitive test results that involve graphomotor responses.
Purpose of the Study:
- To investigate the association between upper extremity impairment and cognitive test performance in PwP.
- To specifically examine graphomotor versus oral responding tasks.
- To assess this relationship in a clinical sample of PwP undergoing Deep Brain Stimulation (DBS).
Main Methods:
- Retrospective chart review of 80 right-hand dominant PwP before DBS surgery.
- Assessed Right Upper Extremity (RUE) impairment using the MDS-UPDRS Part 3.
- Used non-parametric correlations to analyze RUE impairment against graphomotor (e.g., Trail Making Test) and oral tasks.
Main Results:
- No statistically significant association was found between RUE motor impairment and graphomotor cognitive test performance.
- This suggests that dominant upper extremity motor deficits do not substantially impact these specific cognitive assessments in this population.
Conclusions:
- The minimal impact of dominant RUE impairment on graphomotor tasks is noteworthy.
- These findings support the continued use of graphomotor cognitive tests in clinical and research settings for PwP.
- This is particularly relevant for moderately advanced PwP considering or undergoing DBS.
Related Concept Videos
Parkinson's Disease: Treatment
391
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
391
Parkinson's Disease: Overview
723
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
723


